Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-045149
Filing Date
2021-02-16
Accepted
2021-02-16 17:02:58
Documents
1
Group Members
FLAGSHIP PIONEERING, INC.FLAGSHIP VENTURELABS IV, LLCFLAGSHIP VENTURES FUND IV - RX, L.P.FLAGSHIP VENTURES FUND IV, L.P.NOUBAR B. AFEYAN, PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d128674dsc13ga.htm SC 13G/A 131907
  Complete submission text file 0001193125-21-045149.txt   133727
Mailing Address 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund IV General Partner LLC (Filed by) CIK: 0001508051 (see all company filings)

EIN.: 352390209 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Subject) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90749 | Film No.: 21640528
SIC: 2836 Biological Products, (No Diagnostic Substances)